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Accepted 2 May 2012Endometrial cancer is typically diagnosed at an early stage
and is seen mainly in postmenopausal women who present
with abnormal uterine bleeding [1]. The presence of Stage IV
endometrial cancer at the time of the initial diagnosis is
uncommon, and such patients generally have a poor prog-
nosis. The management of these patients remains a clinical
dilemma, although it has been advocated that treatment should
be individually tailored according to the main site of extrap-
elvic spread. A previous study that examined a large number
of patients with stage IVB endometrial cancer who underwent
primary surgical cytoreduction (n¼ 65) revealed that the
median survival of the optimally cytoreduced group was 34
months compared to 11 months for the suboptimally cytore-
duced group [2]. Here, we report the case of a very young
patient with Stage IVB endometrial cancer who was
successfully treated after undergoing a comprehensive
assessment.
In 2007, a 25-year-old nulliparous woman presented with
an unstable gait that had been present for 3 weeks. She visited
an orthopedic outpatient clinic because she was suffering from
progressive left hip pain. The physical examination at this
time revealed limited range of motion of the left hip joint.
Magnetic resonance imaging (MRI) was performed because it
was suspected that the patient was suffering from femo-
roacetabular impingement syndrome. This analysis showed
enhancedsoft tissue in the left ischium and at the junction of
the left acetabulum located anterior to the column-superior
pubic rami in addition to bony cortex destruction (Fig. 1).* Corresponding author. Department of Obstetrics and Gynecology, Chang
Gung Memorial Hospital Linkou Medical Center, 5 Fu-Shin St., Kueishan,
Taoyuan 333, Taiwan.
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http://dx.doi.org/10.1016/j.tjog.2012.07.032Abdominal computed tomography (CT) revealedbilateral iliac
lymphadenopathy and ascites, together with osteolytic bony
lesions in the pelvic cavity. Positron emission tomography
(PET) confirmed lymphadenopathy at the paraaortic and
bilateral iliac lymph nodes and lesions in the left hip (Fig. 2).
CT-guided biopsy of the left acetabulum revealed a poorly
differentiated metastatic carcinoma (Fig. 3). An analysis of
the family history of the patient revealed that the patient’s
mother and uncle (her mother’s brother) had colon cancer and
that her grandfather had gastric cancer. Due to the suspicion of
hereditary nonpolyposis colorectal cancer (HNPCC, Lynch
syndrome), a colonoscopy and a breast ultrasound were per-
formed, both of which yielded negative findings. The patient
received a gynecological oncology consultation, although she
denied experiencing any menstrual abnormalities. Intrigu-
ingly, a hysteroscopy revealed the presence of multiple
endometrial polypoid lesions that were diagnosed as a poor-
ly differentiated adenosquamous carcinoma. She underwent
cytoreductive surgery for advanced endometrial cancer
that included a total hysterectomy, bilateral salpingo-
oophorectomy, bilateral pelvic and para-aortic lymph node
dissection, appendectomy, omentectomy, and multiple intra-
peritoneal excisional biopsies. The patient was optimally
debulked with no gross residual tumor at the conclusion of the
surgery. The histopathological analysis confirmed the pres-
ence of a Grade 3 endometrioid adenocarcinoma with squa-
mous differentiation, 80% myometrial invasion, and
metastases to the bilateral pelvic and para-aortic lymph nodes
and the peritoneal surface of the urinary bladder and the cul-
de-sac. Immunohistochemical analysis revealed that the tumor
was negative for estrogen receptors, progesterone receptors,
HER-2/neu, and epidermal growth factor receptors. The
patient received adjuvant concurrent chemoradiation (CCRT)cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. An axial fat-suppressed contrast-enhanced T1-weighted MR image of
the pelvis showed enhancing soft tissue at the left acetabulum (arrow) and the
left ischium (arrowhead), along with bony cortex destruction.
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weeks for 6 cycles plus radiotherapy consisting of 5040 cGy
in 28 fractions to the pelvic region and the metastastic
bony lesions. The metastatic lesions were further targeted by
image-guided radiotherapy consisting of 2000 cGy/10
fractions (total dose: 7040 cGy). The patient tolerated the
regimen well, and serial imaging studies (including CT and
PET scans, tumor markers, and bone biopsy) performed
42 months after CCRT showed no evidence of recurrence.
Four years later, she has remained disease-free without joint
dysfunction.
To our knowledge, our patient represents the youngest
patient to date to have been diagnosed with stage IVBFig. 2. Positron emission tomography-computed tomography showed increased upt
the para-aortic lymph nodes, (C) the left acetabulum, and (D) the left ischium. Thendometrial cancer with bone metastases. Intensive cytore-
ductive surgery, adjuvant CCRT, and irradiation to the local
bone metastases resulted in long-term disease-free survival. In
the medical literature, the youngest such patient to be reported
previously was a 32-year-old; her case was reported 5 months
after diagnosis, at which time she was alive but continued to
suffer from the disease [3].
Cases of endometrial cancer with bone metastases are rare,
and such findings at the time of diagnosis are even more
uncommon [3]. However, these patients are typically diag-
nosed in the postmenopausal period [3,4]; the reported ages of
these patients range from 32 to 84 years. The sites of bone
metastasis can vary and include the skull, vertebrae, sacrum,
ischium, humerus, femur, fibula, tibia, calcaneus, and
mandible [4]. The process by which these tumors metastasize
to bone remains unclear, although hematogenous dissemina-
tion has been suggested as a potential mechanism [3,5]. The
prognosis of patients with endometrial cancer and bone
metastases is poor, and these patients typically succumb
within 2 years of diagnosis [3]. However, 2 patients were re-
ported to have survived for 5 years at the time the reports were
made [6,7].
As the symptoms of endometrial cancer with bone metas-
tases mimic those of other benign orthopedic diseases,
a diagnosis is often difficult, and clinicians should consider
this type of endometrial cancer as a potential diagnosis for
patients presenting with bone pain. An analysis of the reported
cases of bone metastasis in endometrial cancer reveals that
many of these cases present with complicated clinicalake at (A) the bilateral iliac lymph nodes and the left presacral soft tissue, (B)
e red arrows reveal the lesion sites.
Fig. 3. (A) Biopsy of the left acetabulum lesion revealed poorly differentiated carcinoma with necrosis. (B) Normal bone histology for comparison. Hematoxylin
and eosin stain, magnification 200.
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in bone metastasis, which are only diagnosed after post-
surgical staging [5]. Moreover, it is also quite common to
encounter patients with bone pain of unknown origin whose
endometrial cancer is only discovered following radiation
treatment of the bone metastasis [8,9]. Therefore, it is essential
to investigate the history of the patient carefully and to have
a high index of suspicion. Appropriate imaging analyses, such
as CT, MRI, and PET scans, should prove useful for clarifying
these clinical dilemmas [3,10].
Radiation of the metastatic bony lesion is effective for both
pain relief and disease control [4,9]. However, surgical
resection should be reserved for special cases, such as for
those where calcaneal or ischial amputation is possible [6,10].
The combination of systemic chemotherapy and local radio-
therapy is suggested for patients with multiple bone metas-
tases and intra-abdominal diseases [5]. However, treatment
should be performed on a case-by-case basis.
The patient described here was strongly suspected as
having an HNPCC-related cancer [11]. However, this study
was limited by the lack of genetic testing; such testing was
not performed because the effectiveness of screening for
mismatch repair genes is currently unproven for cases of
endometrial cancer [11]. However, clinicians should bear in
mind that patients who belong to an HNPCC family might be
more likely to develop early-onset cancers, including colo-
rectal cancer and cancers of the endometrium, stomach,
ovary, hepatobiliary tract, small bowel, upper urinary tract,
and brain. The lifetime risk for developing endometrial
cancer is estimated to be 40% to 60% [11]. At present,
a multimodal endometrial screening strategy is emphasized,
whereby endometrial sampling in individuals between the
ages of 30 to 35 years in addition to an annual transvaginal
ultrasound may improve the detection of endometrial cancer
or hyperplasia in asymptomatic women who belong to an
HNPCC family [11, 12]. Hysteroscopy has also been shown
to be useful for detecting premalignant lesions in asymp-
tomatic women [11].Although this condition is rare, this report serves to
emphasize that clinicians should be aware of the possibility of
encountering female patients with early-onset endometrial
cancer metastases who have no gynecological complaints. To
obtain a successful outcome, comprehensive and individual-
ized treatment should be pursued.Acknowledgments
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